Dr. Lal PathLabs Ltd
LALPATHLABDr. Lal PathLabs Ltd
LALPATHLAB
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 74.21 | 13.16 | 0.22% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed Forecastfrom 18 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.
Investor Presentation
View olderPeers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Global Health Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 671.95 | 811.09 | 939.92 | 1,088.14 | 1,249.37 | 1,385.41 | 1,632.60 | 2,139.96 | 2,058.60 | 2,179.90 | ||||||||||
Raw Materials | 139.16 | 172.92 | 197.08 | 226.03 | 262.35 | 298.70 | 397.26 | 502.25 | 447.15 | 1,570.10 | ||||||||||
| Power & Fuel Cost | 11.26 | 12.78 | 13.58 | 15.32 | 15.74 | 16.74 | 18.62 | 22.11 | 25.91 | |||||||||||
| Employee Cost | 134.39 | 136.83 | 152.01 | 180.75 | 208.29 | 242.64 | 273.70 | 364.94 | 376.52 | |||||||||||
| Selling & Administrative Expenses | 106.64 | 119.68 | 149.29 | 175.89 | 208.79 | 184.69 | 176.29 | 253.82 | 270.25 | |||||||||||
| Operating & Other expenses | 112.19 | 139.39 | 162.90 | 194.94 | 214.59 | 244.00 | 279.12 | 383.56 | 407.22 | |||||||||||
EBITDA | 168.31 | 229.49 | 265.06 | 295.21 | 339.61 | 398.64 | 487.61 | 613.28 | 531.55 | 609.80 | ||||||||||
| Depreciation/Amortization | 28.19 | 28.28 | 27.54 | 33.06 | 38.22 | 72.81 | 77.20 | 108.11 | 150.19 | 146.50 | ||||||||||
| PBIT | 140.12 | 201.21 | 237.52 | 262.15 | 301.39 | 325.83 | 410.41 | 505.17 | 381.36 | 463.30 | ||||||||||
| Interest & Other Items | 0.40 | 0.50 | 0.70 | 0.84 | 0.84 | 15.31 | 16.00 | 30.18 | 37.53 | 33.90 | ||||||||||
| PBT | 139.72 | 200.71 | 236.82 | 261.31 | 300.55 | 310.52 | 394.41 | 474.99 | 343.83 | 429.40 | ||||||||||
| Taxes & Other Items | 44.03 | 68.52 | 82.23 | 90.59 | 101.37 | 84.56 | 102.79 | 130.15 | 104.98 | 128.00 | ||||||||||
| Net Income | 95.69 | 132.19 | 154.59 | 170.72 | 199.18 | 225.96 | 291.62 | 344.84 | 238.85 | 301.40 | ||||||||||
| EPS | 17.67 | 19.25 | 18.65 | 20.52 | 23.90 | 27.11 | 34.99 | 41.38 | 28.65 | 36.15 | ||||||||||
| DPS | 1.53 | 2.45 | 3.00 | 4.50 | 6.00 | 12.00 | 20.00 | 12.00 | 6.00 | 12.00 | ||||||||||
| Payout ratio | 0.09 | 0.13 | 0.16 | 0.22 | 0.25 | 0.44 | 0.57 | 0.29 | 0.21 | 0.33 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr. Lal PathLabs Ltd | 93.64 | 13.16 | 0.22% |
| Apollo Hospitals Enterprise Ltd | 95.87 | 12.02 | 0.27% |
| Max Healthcare Institute Ltd | 58.90 | 8.77 | 0.15% |
| Fortis Healthcare Ltd | 49.44 | 3.59 | 0.26% |
Price Comparison
Compare LALPATHLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 1.09%
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Dr. Lal PathLabs Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7836% | Percentage of the fund’s portfolio invested in the stock 1.56% | Change in the portfolio weight of the stock over the last 3 months 0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/65 (+5) |
UTI AMC LTD # UTI MF-UTI MID CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6101% | Percentage of the fund’s portfolio invested in the stock 1.45% | Change in the portfolio weight of the stock over the last 3 months 0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/89 (+5) |
Kotak Equity Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.5263% | Percentage of the fund’s portfolio invested in the stock 0.71% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 51/75 (-6) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Dr. Lal PathLabs Ltd
Events
Dividend Trend
No Trend In Dividends
LALPATHLAB has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Current dividend yield is 0.22%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.23 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 11, 2023
Dividend/Share
₹6.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 11, 2023
Dividend/Share
₹6.00
Ex DateEx Date
Aug 11, 2023
Cash Dividend
Ex DateEx DateAug 5, 2022
Dividend/Share
₹6.00
Ex DateEx Date
Aug 5, 2022
Cash Dividend
Ex DateEx DateJun 22, 2022
Dividend/Share
₹6.00
Ex DateEx Date
Jun 22, 2022
Cash Dividend
Ex DateEx DateAug 18, 2021
Dividend/Share
₹6.00
Ex DateEx Date
Aug 18, 2021
News & Opinions
News Video
Anil Singhvi In Conversation With Dr. Om Manchanda, Managing Director Of Dr Lal PathLabs
1 week ago•Zee Business
News Video
Stock Radar: Breakout with high volumes in Dr Lal PathLabs could lead to a trending phase
2 months ago•The Economic Times
Trade Spotlight | Your strategy to deal in Sun TV Network, Dr Lal PathLabs, Sobha
2 months ago•Moneycontrol
Trade setup for Tuesday: 15 things to know before opening bell
2 months ago•Moneycontrol
Technical Analysis: DLF, Zomato and Dr. Lal PathLabs
3 months ago•The Hindu Businessline
“Dr Lal PathLabs Ltd’s Share Price Rises 0.68% After 43.6% Increase in Profit for Q2 2023”
4 months ago•The Hindu Businessline
Moneycontrol Pro Panorama | Even in a weakened state, China’s overhang over metals to continue
4 months ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 13.6%, vs industry avg of 13.8%
Decreasing Market Share
Over the last 5 years, market share decreased from 3.38% to 3.25%